Defining functional drug-interaction domains on topoisomerase II by exploiting mechanistic differences between drug classes.

Osheroff N, Corbett AH, Elsea SH, Westergaard M
Cancer Chemother Pharmacol. 1994 34 Suppl: S19-25

PMID: 8070023 · DOI:10.1007/BF00684859

MeSH Terms (15)

Amsacrine Animals Anti-Infective Agents Antineoplastic Agents DNA DNA Damage DNA Topoisomerases, Type II Etoposide Fluoroquinolones Genistein Humans Isoflavones Models, Structural Quinolones Topoisomerase II Inhibitors

Connections (1)

This publication is referenced by other Labnodes entities:

Links